Table 2.
Patient | Age, sex | Recurrence | MGMT methylation | Treatment | NP removal | PFS (months) | OS (months) | Status |
---|---|---|---|---|---|---|---|---|
1 | 42, f | 1 | 1 | NT + RX | 1 | 29.1 | 29.1 | 0 |
2 | 59, m | 1 | 0 | NT + RX | 1 | 10.6 | 23.9 | 1 |
3 | 75, f | 1 | 0 | NT | 1 | 5.3 | 7.1 | 1 |
4 | 60, m | 2 | 0 | NT + RX | 0 | 6.9 | 7.1 | 1 |
5 | 65, m | 2 | 1 | NT + RX | 1 | 5.6 | 9.2 | 1 |
6 | 42, m | 4 | 0 | NT | 0 | 2.8 | 3.7 | 1 |
NP nanoparticle, NT nanotherapy, RT radiotherapy, 0 alive, 1 dead
Last update 14 May 2018